Skip to main content

A Study of the Safety and Efficacy of 514G3 in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study of the Safety and Efficacy of 514G3 in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus

A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)

Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery

Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF

Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults

SHIELD II Clinical Investigation

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about SHIELD II Clinical Investigation

Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis

Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fum

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fum

Remission From Stage D Heart Failure

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Remission From Stage D Heart Failure

MOMENTUM 3 IDE Clinical Study Protocol

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about MOMENTUM 3 IDE Clinical Study Protocol

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 143
  • Page 144
  • Page 145
  • Page 146
  • Page 147
  • Page 148
  • Page 149
  • Page 150
  • Page 151
  • …
  • Next page Next
  • Last page Last
Subscribe to